期刊
PEDIATRIC NEPHROLOGY
卷 30, 期 6, 页码 881-887出版社
SPRINGER
DOI: 10.1007/s00467-014-2880-x
关键词
Metabolomics; Biomarkers; Pediatric nephrology
资金
- University of Iowa Institute for Clinical and Translational Science: (ICTS-CTSA) [UL1RR024979]
Metabolomics, the latest of the omics sciences, refers to the systematic study of metabolites and their changes in biological samples due to physiological stimuli and/or genetic modification. Because metabolites represent the downstream expression of genome, transcriptome, and proteome, they can closely reflect the phenotype of an organism at a specific time. As an emerging field in analytical biochemistry, metabolomics has the potential to play a major role in monitoring real-time kidney function and detecting adverse renal events. Additionally, small molecule metabolites can provide mechanistic insights into novel biomarkers of kidney diseases, given the limitations of the current traditional markers. The clinical utility of metabolomics in the field of pediatric nephrology includes biomarker discovery, defining as yet unrecognized biological therapeutic targets, linking of metabolites to relevant standard indices and clinical outcomes, and providing a window of opportunity to investigate the intricacies of environment/genetic interplay in specific disease states.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据